1. Home
  2. CYBN vs MDV Comparison

CYBN vs MDV Comparison

Compare CYBN & MDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYBN
  • MDV
  • Stock Information
  • Founded
  • CYBN 2019
  • MDV 2015
  • Country
  • CYBN Canada
  • MDV United States
  • Employees
  • CYBN N/A
  • MDV N/A
  • Industry
  • CYBN Pharmaceuticals and Biotechnology
  • MDV Transportation Services
  • Sector
  • CYBN Health Care
  • MDV Consumer Discretionary
  • Exchange
  • CYBN Nasdaq
  • MDV Nasdaq
  • Market Cap
  • CYBN 176.5M
  • MDV 147.6M
  • IPO Year
  • CYBN N/A
  • MDV 2022
  • Fundamental
  • Price
  • CYBN $6.08
  • MDV $14.86
  • Analyst Decision
  • CYBN Strong Buy
  • MDV
  • Analyst Count
  • CYBN 3
  • MDV 0
  • Target Price
  • CYBN $85.00
  • MDV N/A
  • AVG Volume (30 Days)
  • CYBN 625.2K
  • MDV 30.1K
  • Earning Date
  • CYBN 11-12-2025
  • MDV 11-05-2025
  • Dividend Yield
  • CYBN N/A
  • MDV 7.87%
  • EPS Growth
  • CYBN N/A
  • MDV N/A
  • EPS
  • CYBN N/A
  • MDV N/A
  • Revenue
  • CYBN N/A
  • MDV $47,273,000.00
  • Revenue This Year
  • CYBN N/A
  • MDV $1.72
  • Revenue Next Year
  • CYBN N/A
  • MDV $3.86
  • P/E Ratio
  • CYBN N/A
  • MDV N/A
  • Revenue Growth
  • CYBN N/A
  • MDV N/A
  • 52 Week Low
  • CYBN $4.81
  • MDV $13.62
  • 52 Week High
  • CYBN $13.88
  • MDV $18.11
  • Technical
  • Relative Strength Index (RSI)
  • CYBN 38.92
  • MDV 47.88
  • Support Level
  • CYBN $6.16
  • MDV $14.57
  • Resistance Level
  • CYBN $6.55
  • MDV $14.99
  • Average True Range (ATR)
  • CYBN 0.49
  • MDV 0.29
  • MACD
  • CYBN -0.06
  • MDV -0.05
  • Stochastic Oscillator
  • CYBN 12.90
  • MDV 33.73

About CYBN Cybin Inc.

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.

About MDV Modiv Industrial Inc. Class C

Modiv Industrial Inc is a pioneer in the direct-to-consumer commercial real estate product industry. It provides individual investors access to real estate and real estate-related investments designed to provide both income and long-term growth. The Company has invested in single-tenant income-producing properties. Its current business consists of owning, managing, operating, leasing, acquiring, investing in and disposing of commercial real estate assets utilized for industrial manufacturing, as well as a few non-core assets. All of the company's consolidated revenues are derived from company's consolidated real estate properties.

Share on Social Networks: